ADVM is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.
HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
MyStockHarbor.com
NEWS SCORE
56/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
28
Weak based on actual EPS/revenue
Confidence
Low
Headline depth
Last Price
$4.36
Trend Context
Mixed / range
Latest briefing
What's happening with ADVM
PR Newswire9 Dec 2025
Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition - PR Newswire
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQb3BRZHdSa3B5dGNJS3U1bmpCMjhnYmNTMHdnSjZjemFSR05NUy1TNDJrRVloX0daRHBMaGQtMl9nOWdHSnVCZkNTS3JoVFBMYVZvMVZGdUZ2YmZ0N3Vnay1YZVR3LW9vVUhIcjA5T1ptdFRXLTFCc1ZYNDAxTy1hZEc1LUxPWnExOExVME52MXJmZW5rN2c3djZKT3pKZjc5VElWZ1J5VnBFbHJqVllPakE1MmViQjdxZjlyaW5QYk5IS3VmVVJFS0ppZHJUVUVEdWhBVVc1ZUNJeTJtLUYwbXBB?oc=5" target="_blank">Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition</a> <font color="#6f6f6f">PR Newswire</…
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Yahoo Finance1 Dec 2025
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNSlI0cGJNbVVna2ZCZF9mRVYwMktsQXFBWWw3R01ZdDEwcjVEMmU3ZkJOcHc0YlZzNk1jSG56QzZqWXJSNk02WERTWTJjUXJrczlTcTJrRHJwaGdnZHpRS1QzeXlqZ1VQUW9kVERra0ZUS2RzUjFsOXNQdVk0OWc1bi1NV1ItZVU2SmtsMndfU2VvZw?oc=5" target="_blank">Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly</a> <font color="#6f6f6f">Yahoo Finance</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Reuters24 Oct 2025
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum - Reuters
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPNDRkODQybWJPYTdlZlBKWUZJRmRKX2tpOFZiSS10QjNXNUxQb2x4RDVwVEV1TVdFU3EyZ0Y4WWxDNzlRZmNBdzI3eng0bTlYNjh2TlR4Rmt0ZDFOTUc1eUxzVWhEeldVLTF4TEo5VllWMU5VbUg0OEhLQlJ3dXBpaS1OQVdFWjQ2V3ZGczg3QktMd2M5ZmNOOGxJc2kxN0VUdEtVYUFzY1ZPa2F4MDIzVEExWFRna0pqVDdCSlFiU2E?oc=5" target="_blank">Eli Lilly bets on eye care with buyout of gene therapy developer Adverum</a> <font color="#6f6f6f">Reuters</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
marketscreener.com
28 Mar 2022
Adverum Biotechnologies, Inc. Stock (ADVM) - Quote Nasdaq - marketscreener.com
